NR 565 Midterm 2026/2027 – 150+ Questions & Answers | Pharmacology, Prescribing, Cardiovascular Drugs, Opioids & DMARDs

This NR 565 Midterm 2026/2027 exam preparation document contains 150+ questions, correct answers, medication facts, prescribing principles, and clinical review concepts across 34 pages. The material provides extensive coverage of advanced pharmacology and prescribing, pharmacokinetics and pharmacodynamics, CYP450 interactions, controlled substances, pain and opioid management, hypertension, heart failure, anticoagulants, lipid-lowering therapy, antiarrhythmics, gout, rheumatoid arthritis medications, DMARDs, and osteoporosis treatment. The document identifies the course code as NR 565 and the academic year as 2026/2027, but no university is named; therefore, the institution is listed as University Not Specified rather than assigning an unsupported affiliation. NR 565 Midterm 2026 The opening portion emphasizes prescriptive authority and safe advanced-practice prescribing. Students review APRN controlled-substance prescribing, state regulation of prescriptive authority, responsibilities of prescribers, medication selection, documentation, patient education, monitoring and titration. The document also discusses older-adult pharmacology, polypharmacy, the Beers Criteria, medication nonadherence, FDA regulation and black-box warnings. Pediatric pharmacology is addressed through neonatal and infant oral, intramuscular and transdermal absorption and age-related changes in drug metabolism. NR 565 Midterm 2026 A substantial section covers pharmacokinetics, pharmacodynamics, pharmacogenetics and CYP450 metabolism. Pharmacokinetics is organized around absorption, distribution, metabolism and excretion (ADME), while pharmacodynamics addresses the biochemical and physiological effects of medications. The review distinguishes CYP450 inhibitors from inducers, explains poor-metabolizer phenotypes and discusses how altered metabolism can affect plasma drug concentrations, therapeutic response and toxicity. Examples in the source include valproate, isoniazid, amiodarone, ketoconazole, grapefruit juice, carbamazepine, rifampin, phenytoin and phenobarbital. NR 565 Midterm 2026 Another major component addresses pain management, opioids and controlled substances. Topics include opioid agonists, morphine milligram equivalents (MME), prescription drug monitoring programs, renal and hepatic impairment, drug diversion, naloxone prescribing, opioid-use disorder, REMS and controlled-substance schedules I–V. Methadone, buprenorphine/naloxone and pregabalin are reviewed alongside opioid overdose warning signs and the document's 12 considerations for safer pain management. The material emphasizes treatment goals, risk-benefit discussions, lowest effective doses, monitoring, PDMP review, urine testing and avoiding potentially hazardous medication combinations. NR 565 Midterm 2026 The cardiovascular pharmacology section provides broad review of hypertension, heart failure, angina, hyperlipidemia and cardiac medication selection. Drug classes include ACE inhibitors, ARBs, beta blockers, calcium-channel blockers, thiazide and loop diuretics, ARNIs and mineralocorticoid/aldosterone receptor antagonists. Medication-specific content includes lisinopril, amlodipine, labetalol, sacubitril/valsartan, spironolactone, eplerenone and nitroglycerin. Students review mechanisms of action, adverse effects, contraindications, pregnancy considerations and laboratory monitoring. NR 565 Midterm 2026 Hyperlipidemia content covers statins and nonstatin lipid-lowering medications, including ezetimibe, niacin, bile-acid sequestrants, fibrates and PCSK9 inhibitors. The study guide differentiates high-, moderate- and low-intensity LDL reduction and reviews statin-associated myopathy, lipid monitoring, hepatic considerations and pregnancy. It also covers lifestyle measures such as weight management, exercise, dietary modification, smoking cessation, the DASH dietary pattern and soluble fiber. NR 565 Midterm 2026 The document also contains focused anticoagulation and antiplatelet pharmacology. Students compare heparin, warfarin, direct oral anticoagulants (DOACs) and antiplatelet medications, with attention to baseline testing, ongoing monitoring, bleeding risk and contraindications. Warfarin content specifically includes PT/INR monitoring and pregnancy considerations, while heparin review includes PTT, platelet and anti-Xa monitoring. NR 565 Midterm 2026 The cardiac rhythm section includes cardioselective and nonselective beta blockers, amiodarone, calcium-channel blockers and digoxin. Students review amiodarone's channel-blocking properties, therapeutic applications and adverse effects, as well as digoxin's effects on AV-node conduction and cardiac contractility. Contraindications and special considerations involving bradycardia, heart block, electrolyte abnormalities and drug interactions are also incorporated. NR 565 Midterm 2026 The final portion concentrates on gout, rheumatoid arthritis, DMARD therapy and osteoporosis. Gout review includes allopurinol, febuxostat, colchicine and NSAIDs, including complications of untreated gout and medication-related adverse effects. Rheumatoid arthritis pharmacology distinguishes conventional DMARDs such as methotrexate, leflunomide, sulfasalazine and hydroxychloroquine from biologic DMARDs such as adalimumab and etanercept and targeted agents such as tofacitinib. Baseline CBC, tuberculosis screening, pregnancy testing and renal/hepatic assessment are included in the source's DMARD review. Osteoporosis treatment focuses on alendronate and bisphosphonate administration, including interactions with calcium, iron, magnesium and antacids and instructions to remain upright after administration. NR 565 Midterm 2026 Relevant students: This document is particularly relevant for NR 565 students, Family Nurse Practitioner (FNP) students, Adult-Gerontology NP students, PMHNP students taking advanced pharmacology, MSN/DNP students, APRN students, graduate nursing students, and nurse practitioner students preparing for advanced pharmacology and prescribing examinations. It is especially useful for learners reviewing safe prescribing, pharmacokinetics, CYP450 interactions, controlled substances, opioid management, cardiovascular pharmacology, anticoagulation, dyslipidemia, gout, rheumatoid arthritis and medication monitoring. Academic references: For deeper study and verification, students can cross-reference the topics with Lehne's Pharmacology for Nursing Care and current prescribing information for individual medications. Because the uploaded review includes clinical recommendations, drug doses and regulatory material that may change over time, current guidelines and official prescribing information should be used to verify such details. These references are supplementary; the uploaded document itself does not identify a particular textbook or journal as the source of its questions. Keywords: NR 565 Midterm, NR 565 Midterm 2026, NR 565 Midterm 2027, NR 565 exam questions and answers, NR 565 study guide, NR 565 advanced pharmacology, advanced pharmacology midterm, nurse practitioner pharmacology, FNP pharmacology exam, APRN prescribing, prescriptive authority, pharmacokinetics, pharmacodynamics, ADME pharmacology, CYP450 inhibitors, CYP450 inducers, pharmacogenetics, Beers Criteria, polypharmacy, controlled substance schedules, opioid prescribing, opioid use disorder, morphine milligram equivalents, MME calculation, naloxone prescribing, PDMP, methadone, buprenorphine naloxone, chronic pain pharmacology, hypertension medications, ACE inhibitors, ARBs, beta blockers, calcium channel blockers, thiazide diuretics, loop diuretics, heart failure pharmacology, sacubitril valsartan, spironolactone, hyperlipidemia medications, statins, ezetimibe, PCSK9 inhibitors, anticoagulants, heparin, warfarin, DOACs, antiplatelet medications, amiodarone, digoxin, gout pharmacology, allopurinol, febuxostat, colchicine, rheumatoid arthritis pharmacology, DMARDs, methotrexate, biologic DMARDs, alendronate, osteoporosis pharmacology, graduate nursing pharmacology, APRN exam questions